Using lab-grown fetal skin tissue to improve wound healing without scars
Cultured human fetal dermal extracellular matrix for scarless wound healing
This study is looking at how lab-grown tissue from human skin can help wounds heal better and without scars, and it's for anyone interested in improving healing for skin injuries.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Broad Institute, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10695076 on NIH RePORTER |
What this research studies
This research investigates the potential of lab-grown human fetal dermal extracellular matrix (ECM) to enhance wound healing without scarring. By biofabricating microtissues using fetal or adult human dermal fibroblasts, the study aims to create a reliable source of ECM that mimics the properties of fetal tissue, which is known for its scarless healing capabilities. The research will also analyze the biochemical and mechanical properties of the ECM to understand how it influences healing. Ultimately, the goal is to evaluate the effectiveness of these cultured ECMs in reducing scarring in skin wounds.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with wounds that are prone to scarring, including those recovering from surgeries or injuries.
Not a fit: Patients with wounds that are not expected to heal or those with conditions that prevent normal healing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to advanced treatments for wounds that heal without scarring, significantly improving patients' quality of life.
How similar studies have performed: Previous research has shown promise in using fetal ECM for wound healing, but this approach of lab-grown tissues is relatively novel and untested.
Where this research is happening
Cambridge, United States
- Broad Institute, INC. — Cambridge, United States (Active)
Researchers
- Principal investigator: Ip, Blanche C — Broad Institute, INC.
- Study coordinator: Ip, Blanche C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.